calanolide b has been researched along with warfarin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyd, MR; Buckheit, RW; Cardellina, JH; Cragg, GM; Currens, MJ; Fuller, RW; Gustafson, KR; Hughes, SH; Kashman, Y; McMahon, JB | 1 |
| Boyd, MR; Cardellina, JH; Fuller, RW; Galinis, DL; Gulakowski, RJ; McKee, TC; McMahon, JB | 1 |
| Bader, JP; Buckheit, RW; Fliakas-Boltz, V; Kinjerski, TL; Osterling, MC; Russell, J; Stup, TL; Weigand, A; White, EL | 1 |
3 other study(ies) available for calanolide b and warfarin
| Article | Year |
|---|---|
The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum.
Topics: Antiviral Agents; Chromatography, Liquid; Coumarins; Cytopathogenic Effect, Viral; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Hydrolysis; Magnetic Resonance Spectroscopy; Pyranocoumarins; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Trees; Tumor Cells, Cultured; Virus Replication | 1992 |
Structure-activity modifications of the HIV-1 inhibitors (+)-calanolide A and (-)-calanolide B.
Topics: Anti-HIV Agents; Antiviral Agents; Coumarins; Cytopathogenic Effect, Viral; Humans; Pyranocoumarins; Structure-Activity Relationship; Tumor Cells, Cultured | 1996 |
Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide.
Topics: Anti-HIV Agents; Benzopyrans; Cells, Cultured; Coumarins; Drug Resistance, Microbial; Drug Synergism; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Microbial Sensitivity Tests; Pyranocoumarins; Reverse Transcriptase Inhibitors; Simian Immunodeficiency Virus; Stereoisomerism | 1999 |